A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2-Reference-Cited by-同舟云学术

A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2

Published:2024-05-03 Issue:5 Volume:7 Page:3238-3246
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Vishweshwaraiah Yashavantha L.¹,Hnath Brianna¹²^ORCID,Wang Jian¹^ORCID,Chandler Morgan³^ORCID,Mukherjee Arnab⁴⁵,Yennawar Neela H.⁶^ORCID,Booker Squire J.⁴⁵⁷^ORCID,Afonin Kirill A.³^ORCID,Dokholyan Nikolay V.¹²³⁸^ORCID

Affiliation:

1. Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania 17033-0850, United States

2. Department of Biomedical Engineering, Penn State University, University Park, Pennsylvania 16802, United States

3. Department of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States

4. Department of Chemistry, Penn State University, University Park, Pennsylvania 16802, United States

5. The Howard Hughes Medical Institute, Penn State University, University Park, Pennsylvania 16802, United States

6. The Huck Institutes of the Life Sciences, Penn State University, University Park, Pennsylvania 16802, United States

7. Department of Biochemistry & Molecular Biology, Penn State University, University Park, Pennsylvania 16802, United States

8. Department of Biochemistry & Molecular Biology, Penn State College of Medicine, Hershey, Pennsylvania 17033-0850, United States

Funder

Penn State College of Medicine

Eberly Foundation

Huck Institutes of the Life Sciences

National Institutes of Health

Passan Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00222

Reference42 articles.

1. World Health Organization. WHO Coronavirus COVID-19 Dashboard, 2023. https://data.who.int/dashboards/covid19/cases.

2. The WHO estimates of excess mortality associated with the COVID-19 pandemic

3. The Many Mutations of the COVID-19 Variant: Current Perspectives on EG.5/Eris

4. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

5. Adaptation‐Proof SARS‐CoV‐2 Vaccine Design